These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 32321728)
1. Methadone rotation for cancer pain: an observational study. Tan C; Wong JF; Yee CM; Hum A BMJ Support Palliat Care; 2022 Dec; 12(e6):e736-e739. PubMed ID: 32321728 [TBL] [Abstract][Full Text] [Related]
2. Comparison of opioid rotation on pain, symptoms, and daily opioid dose in a supportive care clinic. Legakis LP; Woo W; Cassel JB; Del Fabbro E Ann Palliat Med; 2021 Jun; 10(6):6336-6343. PubMed ID: 34118844 [TBL] [Abstract][Full Text] [Related]
3. Methadone Switching for Cancer Pain: A New Classification of Initiation Protocols, Based on a Critical Literature Review. Treillet E; Giet O; Picard S; Laurent S; Seresse L J Palliat Med; 2021 Dec; 24(12):1884-1894. PubMed ID: 34851186 [No Abstract] [Full Text] [Related]
4. The role of methadone in opioid rotation-a Polish experience. Leppert W Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743 [TBL] [Abstract][Full Text] [Related]
5. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450 [TBL] [Abstract][Full Text] [Related]
6. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain. Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675 [TBL] [Abstract][Full Text] [Related]
7. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series. Khoo SY; Aziz FA; Nambbiar P J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444 [TBL] [Abstract][Full Text] [Related]
8. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients. Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687 [TBL] [Abstract][Full Text] [Related]
9. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit. Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964 [TBL] [Abstract][Full Text] [Related]
10. Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study. Reddy A; Haider A; Arthur J; Hui D; Dalal S; Dev R; Tanco K; Amaram-Davila J; Hernandez F; Chavez P; De Moraes AR; Wu J; Nguyen K; Subbiah I; Epner D; Shelal Z; Guay MOD; Mallipeddi T; Bruera E J Pain Symptom Manage; 2023 Jun; 65(6):e683-e690. PubMed ID: 36720398 [TBL] [Abstract][Full Text] [Related]
11. The opioid rotation ratio of hydrocodone to strong opioids in cancer patients. Reddy A; Yennurajalingam S; Desai H; Reddy S; de la Cruz M; Wu J; Liu D; Rodriguez EM; Waletich J; Shin SH; Gayle V; Patel P; Dalal S; Vidal M; Tanco K; Arthur J; Tallie K; Williams J; Silvestre J; Bruera E Oncologist; 2014 Nov; 19(11):1186-93. PubMed ID: 25342316 [TBL] [Abstract][Full Text] [Related]
12. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study. Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946 [TBL] [Abstract][Full Text] [Related]
13. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. Gagnon B; Bruera E J Pain Symptom Manage; 1999 Aug; 18(2):120-5. PubMed ID: 10484859 [TBL] [Abstract][Full Text] [Related]
14. Rotating to oral methadone in advanced cancer patients: a case series. Kilonzo I; Twomey F J Palliat Med; 2013 Sep; 16(9):1154-7. PubMed ID: 23631611 [TBL] [Abstract][Full Text] [Related]
15. Methadone and neuropathic cancer pain subcomponents: a prospective cohort pilot study. Fawoubo A; Perceau-Chambard É; Ruer M; Filbet M; Tricou C; Economos G BMJ Support Palliat Care; 2023 Dec; 13(e2):e273-e277. PubMed ID: 34620692 [TBL] [Abstract][Full Text] [Related]
16. The role of methadone in cancer-induced bone pain: a retrospective cohort study. Sulistio M; Wojnar R; Key S; Kwok J; Al-Rubaie Z; Michael N Support Care Cancer; 2021 Mar; 29(3):1327-1335. PubMed ID: 32627056 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study. Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912 [TBL] [Abstract][Full Text] [Related]
18. Methadone prescribed as an analgesic by a specialist palliative medicine team in an acute hospital inpatient setting: retrospective study. Hayes J; Waldron D; Levins KJ; Gaffney L; Azhar M; Beatty S; Mannion E BMJ Support Palliat Care; 2024 Jan; 13(e3):e839-e842. PubMed ID: 36104162 [TBL] [Abstract][Full Text] [Related]
19. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381 [TBL] [Abstract][Full Text] [Related]
20. The role of methadone in cancer pain treatment--a review. Leppert W Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]